Pontifax, founded in 2004, is an Israeli venture capital firm specializing in investments in incubation, seed or startups, early, and mid stage in the life sciences sector. The firm seeks to invest in companies based in Israel.
Phone: +972 9 9725617
14 Shenkar St.
|2020-03-12||Keros Therapeutics||Series C||$56M||Arkin Holdings, Cowen, Foresite Capital, Medison Pharma, OrbiMed Advisors, Partners Healthcare Innovation, Quark Venture, and Venrock|
|2020-03-11||Silverback Therapeutics||Series B||$78.5M||Alexandria Venture Investments, Bristol-Myers Squibb, Colt Ventures, Hunt Investment Group, Nextech Invest, NS Investment, OrbiMed Advisors, and U.S. Venture Partners|
|2020-01-08||Eyevensys||Series B||$30M||Boehringer Ingelheim Venture Fund, BPI France, CapDecisif Management, Inserm Transfert, Pureos Bioventures, and Quark Venture|
|2019-12-19||Metabomed||Series B||$12.5M||Arkin Holdings, Boehringer Ingelheim Venture Fund, M Ventures, Pfizer Venture Investments, and Yonjin Venture|
|2019-12-18||Raziel Therapeutics||Series C||$22M||Catalyst Fund, Docor International Management, Peregrine Investments, Quark Venture, Shmuel Cabily, and Wille Finance|